A nano-engager for iNKT cells in cancer
Nat Cancer
.
2020 Nov;1(11):1032-1034.
doi: 10.1038/s43018-020-00138-9.
Authors
Mark A Exley
1
2
3
4
,
Thomas Gensollen
5
,
Richard S Blumberg
6
Affiliations
1
Department of Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA. mexley@partners.org.
2
University of Manchester, Manchester, UK. mexley@partners.org.
3
Imvax, Philadelphia, PA, USA. mexley@partners.org.
4
Agentus, Lexington, MA, USA. mexley@partners.org.
5
Department of Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
6
Department of Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA. rblumberg@bwh.harvard.edu.
PMID:
35122067
DOI:
10.1038/s43018-020-00138-9
No abstract available
Publication types
Comment
MeSH terms
Humans
Immunotherapy
Natural Killer T-Cells*
Neoplasms* / therapy